Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by flyingdjon Jun 20, 2018 8:33pm
235 Views
Post# 28202769

Shorts covered - Expect breakout into Phase 2 results.

Shorts covered - Expect breakout into Phase 2 results.

Look at the actual short position as of June 15 - LOWEST in last 6 MONTHS. Ignore the "short data" that is just shorts during the 15 days it is not meaningful as it won't tell you how many are left like this. (LINK BELOW IS SS OF SHORT POSITION)  

https://scontent.fyto1-1.fna.fbcdn.net/v/t1.15752-9/35694842_1921934081191755_2631702096356835328_n.png?_nc_fx=fyyz1-1&_nc_cat=0&_nc_eui2=AeH1P1yXpit_qtGtcJlER3oxI1qCUnAeaQOfsH3z5DDlGh6e4U4cf6Lry3LlCknvWApyQMFHe4_IYvkoS3z78hBKiE7cDiPTl7zHGb5xAGu3DA&oh=04e2c0243c78195858f5857869a81983&oe=5BEC66D6&efg=eyJhZG1pc3Npb25fY29udHJvbCI6MSwidXBsb2FkZXJfaWQiOiItMTkyMTkzNDA4MTE5MTc1NSJ9

Also for everyone saying Salzman is going to sell 9M shares. I am 99% sure this is going to be a CROSS-TRADE between another broker. Ridiculous to think they would sell on market price - this would serverely impact their payment $ value and makes no sense. 

Technicals wise - KALY breaking .19 tomorrow leaves no ceiling left. I am calling 30-35 cents by next week as I'm sure they have an NR or two and JUNE 27TH is CBD CATALYST. 

Bullboard Posts